Doctors can replace organs and fight cancer, so why does the brain still remain so difficult to treat with drugs?

Modern medicine has achieved things that once seemed impossible.

Surgeons can replace heart valves, transplant organs, and develop targeted therapies for cancers.

Yet one organ continues to test the limits of science: the human brain.For neurologists, the problem is often not a lack of medicines.

It is getting those medicines to where they are needed.According to Dr Umesh T, Clinical Director, Head of Academics, and Senior Consultant Neurologist at CARE Hospitals, Banjara Hills, "For all the advances in modern medicine, the brain still remains one of the hardest organs to treat.

In neurology and neuro-oncology, one of the biggest frustrations is that many medicines never actually reach the area where they are needed."The reason lies in a remarkable biological structure called the blood-brain barrier.The brain consumes about 20% of the body's oxygen, despite accounting for only around 2% of body weight.

Because it controls every movement, thought, and emotion, it cannot afford exposure to harmful substances.This is where the blood-brain barrier (BBB) comes in.Dr Umesh explained, "The blood-brain barrier, often shortened to BBB, is a protective lining around the brain's blood vessels.

Its function is simple: keep harmful substances out."Unlike blood vessels elsewhere in the body, those supplying the brain are tightly sealed by specialized cells.

These cells act like highly selective guards.

Oxygen and nutrients are allowed to pass, but many chemicals, toxins, bacteria, and unfortunately, medicines are turned away.From an evolutionary perspective, this barrier is a blessing.

Without it, infections and toxic substances could easily damage delicate nerve cells.

But for doctors treating neurological diseases, it creates a frustrating obstacle.The National Institute of Neurological Disorders and Stroke (NINDS), part of the US National Institutes of Health, describes the BBB as one of the major reasons why developing effective brain therapies remains difficult.A drug that works beautifully in laboratory experiments may fail in real patients simply because it cannot cross into the brain."Treating neurological disease is not only about finding the right drug.

It is also about delivery," said Dr Umesh.He added, "A medication can appear promising in laboratory research and still fail in human trials because it cannot cross the blood-brain barrier efficiently."This challenge affects a wide range of diseases, including:​Brain tumorsAlzheimer's diseaseParkinson's diseaseCertain forms of epilepsyBrain infectionsAutoimmune neurological disordersPerhaps nowhere is this more apparent than in glioblastoma, one of the most aggressive forms of brain cancer.

Patients may receive intensive chemotherapy, but only a small amount of the medicine reaches the tumor.Increasing the dose is not always an option."Higher doses often mean greater toxicity to the liver, kidneys, bone marrow, and gastrointestinal tract," Dr Umesh explained.Researchers around the world are no longer asking whether drugs can cross the blood-brain barrier.

Instead, they are exploring ways to briefly bypass it without harming the brain.One promising approach involves focused ultrasound.Dr Umesh said, "In this approach, ultrasound waves are aimed at a specific part of the brain after tiny bubbles are injected into the bloodstream.

For a short time, this helps open the brain's protective barrier just enough for medicines to pass through more easily."The opening lasts only temporarily, which is important for safety.

Early studies have produced encouraging results, particularly in patients with brain tumors.Another area attracting attention is nanotechnology."Nanoparticles are essentially microscopic carriers engineered to transport medication.

Researchers hope nanoparticle delivery could eventually reduce side effects while improving drug concentration inside diseased areas of the brain," Dr Umesh explained.Scientists are also experimenting with modified viruses that can deliver genetic instructions directly into brain cells.

Although the idea sounds unsettling, these viruses are engineered so they do not cause disease.Meanwhile, some researchers are studying implantable devices capable of slowly releasing medicines directly into brain tissue.One of the lesser-known truths in neurology is that many potentially effective drugs may never fulfill their promise because they cannot reach the right target."In many cases, researchers are not dealing with weak drugs.

They are dealing with poor access," said Dr Umesh.This reality has changed how scientists think about brain diseases.

For decades, the focus was on discovering new molecules.

Increasingly, attention is shifting toward how those molecules can be delivered.It is a bit like having the perfect key but being unable to reach the locked door.The challenge is so significant that entire fields of medicine, including neuropharmacology and molecular engineering, have emerged around solving this one problem.This article includes expert inputs shared with TOI Health by:Dr Umesh T, Clinical Director, Head of Academics, & Senior Consultant - Neurologist, CARE Hospitals, Banjara Hills.Inputs were used to explain why the brain remains one of the most difficult organs to treat, how the blood-brain barrier prevents many medicines from reaching diseased tissue, and why scientists are exploring new ways to deliver drugs more effectively for neurological disorders.